Skip to main content
Home

Main navigation

  • Home
  • About
  • Team
  • Investments
  • News
  • Contact
Naveris logo
April 12, 2023
Mayo Clinic Collaborates with Naveris to Advance Precision Medicine in HPV-driven Head and Neck Cancer

Read

Radius Health
March 8, 2023
Theramex enters into an exclusive licensing agreement with Radius Health Inc, to commercialise ELADYNOS®

Read

Corium Pharma Solutions logo
March 1, 2023
Corium Pharma Solutions Names Suzanne Hinchliffe as Chief People Officer

Read

Radius Health
January 30, 2023
Radius Licensee Receives FDA Approval for ORSERDU™ (elacestrant)

Read

Radius Health
January 30, 2023
Teijin Pharma to Launch Japan-market Sales of Abaloparatide Acetate for Osteoporosis

Read

Innocoll Biotherapeutics logo
January 26, 2023
Innocoll Holdings Ltd. Appoints Kimball Hall as Chief Executive Officer

Read

Corium Pharma Solutions logo
January 17, 2023
Corium Pharma Solutions Appoints Mark Sirgo as Chief Executive Officer

Read

Radius Health
December 20, 2022
TYMLOS® (abaloparatide) Receives U.S. FDA Approval for Increase Bone Density in Men with Osteoporosis

Read

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Next page Next ›
  • Last page Last »

Gurnet Point Capital
55 Cambridge Parkway
Suite 401
Cambridge, MA 02142

Contact Us

Gurnet Point Capital © 2023. Please take a moment to read the Legal Notice / Privacy Statement.